Human Formulations

lodide IP 1 gm + Potassium lodide IP 2 gm + Tannic Acid IP 0.5 gm + Thymol IP 0.25 gm + Menthol IP 0.25 gm camphor IP 0.20 gm + Glycerin IP 94.3 gm + Alum IP 1.5 gm Gum Paint

lodide IP 1 gm + Potassium lodide IP 2 gm + Tannic Acid IP 0.5 gm + Thymol IP 0.25 gm + Menthol IP 0.25 gm camphor IP 0.20 gm + Glycerin IP 94.3 gm + Alum IP 1.5 gm Gum Paint is a gum paint formulated with lodide IP 1 gm + Potassium lodide IP 2 gm + Tanni

Topical FormulationsOintment & Cream Single Ingredient Gum Paint
Sterile injectable formulation

Product information

Product Line
Human Formulations
Category
Topical Formulations, Ointment & Cream
Dosage Form
Gum Paint
Product Type
Single Ingredient

Available strengths

lodide IP 1 gm + Potassium lodide IP 2 gm + Tannic Acid IP 0.5 gm + Thymol IP 0.25 gm + Menthol IP 0.25 gm camphor IP 0.20 gm + Glycerin IP 94.3 gm + Alum IP 1.5 gm

Description

lodide IP 1 gm + Potassium lodide IP 2 gm + Tannic Acid IP 0.5 gm + Thymol IP 0.25 gm + Menthol IP 0.25 gm camphor IP 0.20 gm + Glycerin IP 94.3 gm + Alum IP 1.5 gm Gum Paint is a gum paint formulated with lodide IP 1 gm + Potassium lodide IP 2 gm + Tannic Acid IP 0.5 gm + Thymol IP 0.25 gm + Menthol IP 0.25 gm camphor IP 0.20 gm + Glycerin IP 94.3 gm + Alum IP 1.5 gm. The listed active ingredient profile is lodide gm; Potassium lodide gm; Tannic Acid gm; Thymol gm; Menthol gm camphor gm; Glycerin gm; Alum gm, placing the product in the topical analgesic / musculoskeletal category. The formulation contains topical analgesic/counter-irritant ingredients intended for localized musculoskeletal pain relief where appropriate. The dosage form is intended for topical/local application; the exact application site and frequency must follow the approved product instructions. For website cataloguing, the composition, strength, dosage form and formulation characteristics should be displayed prominently and consistently. The product description should remain factual and should not include unapproved cure, superiority, guaranteed-result or broad therapeutic claims. Clinical selection should depend on diagnosis, patient-specific factors, contraindications, concomitant medicines and professional judgement. Prescription status, warnings, interactions, adverse effects and dosing or application instructions must be checked against the current approved product label. Manufacturer, licence, storage, shelf-life, reconstitution where applicable, and market-specific regulatory details should be added only from verified product documentation.
WHO-GMP Sourced
Sterile Supply
Regulatory Documentation
Quality Assured